Significant adverse effect: increase in self‐reported tinnitus loudness · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects associated with wearing the device (such as pain, discomfort, tenderness or skin irritation, or ear infections) · adults with subjective idiopathic tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival ‐ Gemcitabine plus topoisomerase inhibitor · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus topoisomerase inhibitor compared with gemcitabine alone (high certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus taxane · advanced pancreatic cancer
Gemcitabine combinations leads to lower overall survival ‐ Gemcitabine plus taxane compared with gemcitabine alone (high certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus other agent(s) · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus other agent(s) compared with gemcitabine alone (low certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus platinum agent · advanced pancreatic cancer
Gemcitabine combinations showed no clear difference in overall survival ‐ Gemcitabine plus platinum agent compared with gemcitabine alone (low certainty).
1 finding from 1 review
Overall survival ‐ Gemcitabine plus fluoropyrimidine · advanced pancreatic cancer
Gemcitabine combinations leads to lower overall survival ‐ Gemcitabine plus fluoropyrimidine compared with gemcitabine alone (high certainty).
1 finding from 1 review
Outcomes after 1‐ to 2‐year · s of women with dense and non‐dense breasts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
False‐positive rate · s of women with dense and non‐dense breasts
Mammography in combination with breast ultrasonography leads to higher false‐positive rate compared with mammography alone (high certainty).
1 finding from 1 review
False‐negative rate · s of women with dense and non‐dense breasts
Mammography in combination with breast ultrasonography probably leads to lower false‐negative rate compared with mammography alone (moderate certainty).
1 finding from 1 review
Rate of biopsies · s of women with dense and non‐dense breasts
Mammography in combination with breast ultrasonography leads to higher rate of biopsies compared with mammography alone (high certainty).
1 finding from 1 review
Outcomes after 1‐ to 2‐year · breast cancer screening in women at average risk with dense breasts
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incremental cancer detection in women with dense breasts: cohort studies · breast cancer screening in women at average risk with dense breasts
Mammography in combination with breast ultrasonography showed no clear difference in incremental cancer detection in women with dense breasts: RCT compared with mammography alone (high certainty).
2 findings from 1 review
Incremental detection of invasive cancers · breast cancer screening in women at average risk with dense breasts
Mammography in combination with breast ultrasonography showed no clear difference in incremental detection of invasive cancers compared with mammography alone (low certainty).
1 finding from 1 review
Interval cancer · breast cancer screening in women at average risk with dense breasts
Mammography in combination with breast ultrasonography showed no clear difference in interval cancer compared with mammography alone (high certainty).
1 finding from 1 review
False‐positive rate in women with dense breasts · breast cancer screening in women at average risk with dense breasts
Mammography in combination with breast ultrasonography leads to higher false‐positive rate in women with dense breasts compared with mammography alone (high certainty).
1 finding from 1 review
False‐negative rate in women with dense breasts · breast cancer screening in women at average risk with dense breasts
Mammography in combination with breast ultrasonography probably leads to lower false‐negative rate in women with dense breasts compared with mammography alone (moderate certainty).
1 finding from 1 review